4/A

FORM 4/A SUBMISSION

Company: BridgeBio Pharma, Inc.
Filed: December 13, 2018
Period of Report: December 6, 2018
Accession Number: 0000899243-18-030927

View Document ↗ View on SEC.gov ↗